Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 14, 2023; 29(42): 5728-5750
Published online Nov 14, 2023. doi: 10.3748/wjg.v29.i42.5728
Published online Nov 14, 2023. doi: 10.3748/wjg.v29.i42.5728
Table 3 Stability of anti-chitinase 3-like 1 autoantibodies status over time in patients with Crohn’s disease during the disease course
| Serologic antibodies | (Sub)type | n | Stable negative, n (%) | Stable positive, n (%) | Negative to positive, n (%) | Positive to negative, n (%) |
| aCHI3L1 | IgG | 165 | 152 (92.1) | 2 (1.2) | 2 (1.2) | 9 (5.5) |
| IgA | 165 | 92 (55.8) | 39 (23.6) | 17 (10.3) | 17 (10.3) | |
| sIgA | 165 | 83 (50.3) | 51 (30.9) | 14 (8.5) | 17 (1.1) |
- Citation: Sipeki N, Kovats PJ, Deutschmann C, Schierack P, Roggenbuck D, Papp M. Location-based prediction model for Crohn’s disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies. World J Gastroenterol 2023; 29(42): 5728-5750
- URL: https://www.wjgnet.com/1007-9327/full/v29/i42/5728.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i42.5728